Basal cell carcinoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (10 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Basal cell carcinoma}} | {{Basal cell carcinoma}} | ||
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D. | {{CMG}} {{AE}} Saarah T. Alkhairy, M.D.,{{M.N}} | ||
==Overview== | ==Overview== | ||
A skin biopsy and chemotherapeutic agents such as 5-Fluorouracil or Imiquimod may prevent the further development of basal cell carcinoma. | A skin [[biopsy]] and [[chemotherapeutic agents]] such as [[5-Fluorouracil]] or [[Imiquimod]] may prevent the further [[development]] of basal cell carcinoma. | ||
==Basal Cell Carcinoma Secondary Prevention== | ==Basal Cell Carcinoma Secondary Prevention== | ||
*Skin biopsy | *Skin [[biopsy]] | ||
:* | :*To view the [[biopsy]] [[algorithm]] of a suspected [[lesion]] , click [[Basal cell carcinoma laboratory tests|'''here''']]<br> | ||
[[ | *[[Chemotherapeutic agents]] such as [[5-Fluorouracil]] or [[Imiquimod]]<ref name="pmid27459394">{{cite journal |vauthors=Linos E, Katz KA, Colditz GA |title=Skin Cancer-The Importance of Prevention |journal=JAMA Intern Med |volume=176 |issue=10 |pages=1435–1436 |date=October 2016 |pmid=27459394 |pmc=5489348 |doi=10.1001/jamainternmed.2016.5008 |url=}}</ref><ref name="KohGeller2004">{{cite journal|last1=Koh|first1=Howard K.|last2=Geller|first2=Alan C.|title=Skin cancer prevention comes of age|journal=American Journal of Preventive Medicine|volume=27|issue=5|year=2004|pages=484–485|issn=07493797|doi=10.1016/j.amepre.2004.08.011}}</ref> | ||
*Chemotherapeutic agents such as 5-Fluorouracil or Imiquimod | :*It is usually recommended to individuals with extensive [[Sun exposure|sun damage]], history of multiple [[skin cancers]], or [[precancerous]] growths | ||
:*It is usually recommended to individuals with extensive sun damage, history of multiple skin cancers, or precancerous growths | :*It is often repeated every 2 to 3 years | ||
:*It is often repeated every 2 to 3 years | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | {{WH}} | ||
{{WS}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category: | [[Category:Surgery]] | ||
Latest revision as of 15:24, 6 March 2019
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma secondary prevention |
|
Risk calculators and risk factors for Basal cell carcinoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D., Maneesha Nandimandalam, M.B.B.S.[2]
Overview
A skin biopsy and chemotherapeutic agents such as 5-Fluorouracil or Imiquimod may prevent the further development of basal cell carcinoma.
Basal Cell Carcinoma Secondary Prevention
- Skin biopsy
- Chemotherapeutic agents such as 5-Fluorouracil or Imiquimod[1][2]
- It is usually recommended to individuals with extensive sun damage, history of multiple skin cancers, or precancerous growths
- It is often repeated every 2 to 3 years
References
- ↑ Linos E, Katz KA, Colditz GA (October 2016). "Skin Cancer-The Importance of Prevention". JAMA Intern Med. 176 (10): 1435–1436. doi:10.1001/jamainternmed.2016.5008. PMC 5489348. PMID 27459394.
- ↑ Koh, Howard K.; Geller, Alan C. (2004). "Skin cancer prevention comes of age". American Journal of Preventive Medicine. 27 (5): 484–485. doi:10.1016/j.amepre.2004.08.011. ISSN 0749-3797.